pdCSM-GPCR

pdCSM-GPCR predicts potent small-molecule ligands for G protein-coupled receptors (GPCRs) using graph-based signatures to support identification and prioritization of GPCR ligands in drug discovery.


Key Features:

  • Graph-Based Signatures: Uses graph-based signatures to model ligand–GPCR interactions.
  • Comprehensive Predictive Models: Built from curated bioactivity data (IC50, EC50, Ki, and Kd) for 36 GPCR targets across classes A, B, C, and F.
  • High Performance: Validated by stratified 10-fold cross-validation and blind tests achieving Pearson correlations up to 0.89 and outperforming previous methods.
  • Feature Identification: Identified structural features associated with potent GPCR ligands, including bicyclic rings and increased aromaticity.

Scientific Applications:

  • Drug Discovery and Development: Screens and prioritizes compound libraries for potential GPCR ligands to guide experimental validation.
  • Research and Analysis: Provides insights into structural determinants of ligand potency to support studies of GPCR–ligand interactions.

Methodology:

Curated bioactivity data (IC50, EC50, Ki, and Kd) for 36 GPCR targets across classes A, B, C, and F and used graph-based signatures to construct predictive models evaluated by stratified 10-fold cross-validation and blind tests.

Topics

Collections

Details

Cost:
Free of charge
Tool Type:
web application
Operating Systems:
Mac, Linux, Windows
Added:
5/19/2022
Last Updated:
11/24/2024

Operations

Publications

Velloso JPL, Ascher DB, Pires DEV. pdCSM-GPCR: predicting potent GPCR ligands with graph-based signatures. Bioinformatics Advances. 2021;1(1). doi:10.1093/bioadv/vbab031. PMID:34901870. PMCID:PMC8651072.

PMID: 34901870
PMCID: PMC8651072
Funding: - The Medical Research Council: MR/M026302/1 - Wellcome Trust: 093167/Z/10/Z - Investigator Grant from the National Health and Medical Research Council (NHMRC) of Australia: GNT1174405 - Coordenação de Aperfeiçoamento de Pessoal de Nível Superior—Brasil: 001